Latest United States News

6K Additive has completed a six-year, US$27.4 million secured loan with the US Export-Import Bank to expand production of critical metal powders in Pennsylvania. The financing gives the company access to project funding through June 2028, but the final interest rate and the expansion’s eventual output remain to be established.

Steadfast Group has disclosed a notice from Pentwater Capital Management concerning equity derivatives under Takeovers Panel guidance. The filing does not reveal the position’s size, direction, counterparties or economic exposure, leaving its significance unresolved.

Stakk has executed a five-year US$9 million agreement with US banking technology provider Candescent, with its AI-powered cheque and document intelligence already deployed. The contract commits approximately US$1.8 million in annual revenue through 2030 and is expected to contribute above Stakk’s FY2027 revenue milestone.

Stakk Limited (ASX:SKK) delivered a sharp FY2026 revenue increase and moved to audited operating profitability, but its next test is considerably larger: integrating ParaScript while servicing new debt and converting contracted revenue into cash. The company is targeting A$55.2 million of pro forma revenue and A$18.5 million of EBITDA in FY2027.

Stonehorse Energy returned to profit in FY2026 as Canadian production and oil exposure lifted revenue, while the company sold its US assets after year-end. The next test is whether Drumheller can convert production growth into sustainable cash flow while carrying new debt.

Atomos Limited (ASX:AMS) returned to profit in FY26 as revenue rose 22.5% and EBITDA swung positive, but the recovery remains financially fragile. The video technology group continues to carry negative net assets, used cash in operations and faces a possible covenant shortfall in the December half.

Norwood Systems delivered higher revenue, record customer receipts and a sharp reduction in operating cash outflow in FY2026. But the ASX-listed AI voice company remains loss-making, cash-light and subject to a material going-concern uncertainty.

Kelsian Group has completed the $149.9 million sale of its Tourism Portfolio to Journey Beyond, reducing pro forma leverage to approximately 2.0x. The transport operator has reset FY27 Underlying EBITDA guidance to $295 million-$310 million as it shifts towards commuter and contracted services.

Pure Resources finished 2026 with $3.67 million in cash and no debt after raising $4.7 million, but its annual loss widened as it shifted from explorer to a Garnet Hills-led advanced materials platform. The company is now pursuing garnet abrasives, jumbo flake graphite and heavy rare earth recovery through US research and defence partnerships.

Dalaroo Metals has moved from a Western Australian base-metals explorer into a three-country gold and critical-minerals play, but its next phase depends on drilling success and continued access to capital. The annual report records a $2.63 million loss, $509,442 in year-end cash and a material uncertainty over going concern.

Clarity Pharmaceuticals is approaching pivotal Phase III readouts for its prostate cancer imaging agent, backed by AUD178.3 million in liquid assets. The radiopharmaceutical developer remains deeply loss-making, but expanded manufacturing capacity and early clinical signals are pulling its commercial ambitions into sharper focus.

Vection Technologies delivered its first positive full-year operating cash flow and a sharp rise in adjusted EBITDA in FY26. Yet the audited report warns that continued operations depend on stronger sales, margin gains, cost reductions and potential access to further capital.